Literature DB >> 24903642

Pseudotumoral forms of multiple sclerosis: report of 14 cases and review of the literature.

Lara Mauri-Fábrega1, María Díaz-Sánchez, José Luis Casado-Chocán, Antonio José Uclés-Sánchez.   

Abstract

BACKGROUND: The pseudotumoral form of multiple sclerosis (MS) is a rare condition with few descriptions in the literature. It supposes a diagnostic challenge especially when appearing at the onset of disease.
METHODS: We retrospectively describe a case series of pseudotumoral MS patients that attended our hospital from 2004, analyzing demographic, clinical and radiological variables. We classified the lesions according to the recently proposed morphologic classification (infiltrative, megacystic, Baló or ring-like) and according to the contrast enhancement pattern (nodular, complete ring, incomplete ring and diffuse).
RESULTS: Fourteen patients (11 female, 3 male), with a mean age of 35 years, were identified. All of them suffered from a relapsing-remitting form of MS. Eleven patients (78.57%) had symptomatic pseudotumoral lesions (PL), being the form of clinical presentation in the majority of those patients that were symptomatic (81.81%). Several patients presented atypical clinical manifestations such as cognitive impairment (21.42%) and epileptic seizures (14.28%). Full recovery was found in 53.84% of all symptomatic episodes. After a mean follow-up of 43 months, recurrent PL episodes were seldom observed (21.42%), the annualized relapse rate was 0.95 and the mean final Expanded Disability Status Scale score was 1.5. The majority of PLs were supratentorial, coexisted with typical demyelinating plaques and showed the ring-like morphology and the ring pattern of contrast enhancement. Three patients had more than one PL on the same scan, all of the lesions with similar morphology.
CONCLUSIONS: Our findings contribute to a better characterization of pseudotumoral forms of MS. However, larger studies are required to define this atypical entity more exactly.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 24903642     DOI: 10.1159/000358385

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  5 in total

Review 1.  Differential imaging of atypical demyelinating lesions of the central nervous system.

Authors:  Matteo Paoletti; Shaun Ivan Muzic; Francesca Marchetti; Lisa Maria Farina; Stefano Bastianello; Anna Pichiecchio
Journal:  Radiol Med       Date:  2021-01-24       Impact factor: 3.469

2.  Central nervous system Aquaporin4 autoimmunity revealed by a single pseudotumoral encephalic lesion.

Authors:  Guillaume Fargeot; J Aboab; J Savatovsky; R Marignier; A Lecler; O Gout
Journal:  Metab Brain Dis       Date:  2017-10-31       Impact factor: 3.584

Review 3.  Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts.

Authors:  Thomas Berger; Irina Elovaara; Sten Fredrikson; Chris McGuigan; Lucia Moiola; Kjell-Morten Myhr; Celia Oreja-Guevara; Igor Stoliarov; Uwe K Zettl
Journal:  CNS Drugs       Date:  2017-01       Impact factor: 5.749

4.  Tumefactive multiple sclerosis versus high-grade glioma: A diagnostic dilemma.

Authors:  Heath David French
Journal:  Surg Neurol Int       Date:  2021-05-03

5.  Tumefactive multiple sclerosis versus high grade glioma: A diagnostic dilemma.

Authors:  Heath French; Ariadna Fontes-Villalba; Monish Maharaj; Catherine Soo Yee Naidoo; Kartik Bhatia; Amanda Paterson; Raymond Cook; John Parratt
Journal:  Surg Neurol Int       Date:  2022-04-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.